Found: 21
Select item for more details and to access through your institution.
Beta-cell regeneration from vimentin<sup>+</sup>/MafB<sup>+</sup> cells after STZ-induced extreme beta-cell ablation.
- Published in:
- Scientific Reports, 2015, p. 11703, doi. 10.1038/srep11703
- By:
- Publication type:
- Article
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo.
- Published in:
- Protein & Cell, 2018, v. 9, n. 10, p. 867, doi. 10.1007/s13238-017-0384-8
- By:
- Publication type:
- Article
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers.
- Published in:
- Protein & Cell, 2018, v. 9, n. 10, p. 838, doi. 10.1007/s13238-017-0440-4
- By:
- Publication type:
- Article
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.
- Published in:
- Protein & Cell, 2018, v. 9, n. 6, p. 516, doi. 10.1007/s13238-017-0394-6
- By:
- Publication type:
- Article
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment.
- Published in:
- Protein & Cell, 2017, v. 8, n. 12, p. 896, doi. 10.1007/s13238-017-0400-z
- By:
- Publication type:
- Article
Characteristics of premanufacture CD8<sup>+</sup>T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01659-2
- By:
- Publication type:
- Article
Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
- Published in:
- Diabetes, 2012, v. 61, n. 6, p. 1616, doi. 10.2337/db11-1141
- By:
- Publication type:
- Article
Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-00915-1
- By:
- Publication type:
- Article
Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-00915-1
- By:
- Publication type:
- Article
Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 10, p. 2513, doi. 10.1002/eji.202049107
- By:
- Publication type:
- Article
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20696-x
- By:
- Publication type:
- Article
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00856-8
- By:
- Publication type:
- Article
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0741-6
- By:
- Publication type:
- Article
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.
- Published in:
- SCIENCE CHINA Life Sciences, 2016, v. 59, n. 5, p. 468, doi. 10.1007/s11427-016-5023-8
- By:
- Publication type:
- Article
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.
- Published in:
- SCIENCE CHINA Life Sciences, 2016, v. 59, n. 4, p. 379, doi. 10.1007/s11427-016-5035-4
- By:
- Publication type:
- Article
Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 779, doi. 10.20892/j.issn.2095-3941.2023.0324
- By:
- Publication type:
- Article
Staphylococcus enterotoxin B-induced T cells can efficaciously protect against type 1 diabetes in non-obese diabetic mice.
- Published in:
- Central European Journal of Immunology, 2015, v. 40, n. 3, p. 292, doi. 10.5114/ceji.2015.54589
- By:
- Publication type:
- Article
Co-infusion of haplo-identical CD19- chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0357-z
- By:
- Publication type:
- Article
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects.
- Published in:
- 2016
- By:
- Publication type:
- journal article